-
Carl Icahn's New Stake In Allergan
Tuesday, May 31, 2016 - 10:16am | 250Read More...The billionaire investor confirmed through his Twitter account that he has acquired a "large position" in Allergan plc Ordinary Shares (NYSE: AGN). Shares of Allergan were trading higher by more than 2.5 percent after Tuesday's opening bell. Icahn also said in a statement is he is...
-
#PreMarket Primer: Wednesday, February 19: Tesla Earnings Expected Today
Wednesday, February 19, 2014 - 8:19am | 816Read More...Despite being closed on Monday, U.S. markets had a relatively quiet day Tuesday. The Dow lost about 24 points to close at 16,130.40. The S&P was up 0.1 percent, or about two points, to 1,840.76 and the NASDAQ saw a sharp rise to finish 0.7 percent higher at 4,272.78. Wednesday morning, U....
-
Market Wrap For January 17: Stocks Finish Week With Mixed Results
Friday, January 17, 2014 - 5:40pm | 2758Read More...Stocks traded mostly lower today as investors digested a new set of earnings that were disappointing. A mixed housing data and a consumer sentiment coming in lower than expected was enough to tame the bulls as major indices finished the day mixed. Markets will be closed on Monday for Martin...
-
Market Wrap For December 2: Markets Sluggish on Cyber Monday
Monday, December 2, 2013 - 5:50pm | 1882Read More...Despite a positive note by a leading analyst at Morgan Stanley (NYSE: MS), major markets suffered a post-turkey Thanksgiving hangover as major indices closed in the red. Adam Parker, Morgan Stanley's lead strategist predicted the S&P will hit 2014… in 2014, an approximate 11.5 percent gain...
-
Icahn Sells Portion of Netflix Stakes – Wins Big
Wednesday, October 23, 2013 - 8:15am | 529Read More...Reuters is reporting that billionaire activist investor, Carl Icahn has sold a portion of his Netflix (NASDAQ: NFLX) stake netting him between $700 and $800 million. Icahn bought a nine percent stake in the company in August of 2012 at an average price of $58 per share. He sold three million...
-
Carl Icahn's Top Six Positions
Wednesday, October 2, 2013 - 7:05am | 711Read More...Tuesday, Carl Icahn made news when he tweeted that he had dinner with Apple (NASDAQ: AAPL) CEO Tim Cook to discuss increasing its share buyback. Icahn revealed his long position in Apple on August 13 and according to his CNBC interview Tuesday, Icahn now owns about $2 billion worth of Apple...
-
Bank Of America Raises Price Target On Forest Labs To $45
Tuesday, June 28, 2011 - 7:33am | 146Read More...According to Bank of America, Forest Labs (NYSE: FRX) price target is raised to $45. Bank of America said that it is raising its PO to $45 (from $40) to reflect value for Namenda XR, which it assumes preserves some value for the franchise post-generic Namenda, as well as some additional cost...
-
Bank of America Raises PO On Forest Labs To $45
Tuesday, June 28, 2011 - 6:44am | 20Read More...Bank of America has raised the price objective on Forest Labs (NYSE: FRX) from $40 to $45 and maintains its Buy rating.
-
Forest Labs and Watson Pharma to Open Near 52-Week Highs
Thursday, June 23, 2011 - 8:44am | 288Read More...Forest Laboratories (NYSE: FRX) and Watson Pharmaceuticals (NYSE: WPI) reached new 52-week highs of $40.52 and $66.00 per share, respectively, in Wednesday's trading session. Forest Labs saw an upgrade from Argus and Duncan-Williams upgraded its price target on the stock to $45 in the wake of...
-
Bank of America Merrill Lynch Maintains Buy on Forest Labs
Thursday, June 23, 2011 - 7:35am | 133Read More...Bank of America Merrill Lynch is out with its report today on Forest Labs (NYSE: FRX), maintaining Buy. In a note to clients, Bank of America Merrill Lynch writes, "FRX faces big revenue and EPS cliffs after Lexapro goes generic in March 2012, but we believe this is largely factored into valuation...
-
Colgate and Forest Labs to Open Near 52-Week Highs
Tuesday, June 21, 2011 - 8:22am | 255Read More...Colgate-Palmolive (NYSE: CL) and Forest Laboratories (NYSE: FRX) reached new 52-week highs of $89.28 and $39.56 per share, respectively, late in Monday's trading session. Colgate just announced the completion of its purchase of the Sanex personal care brand from Unilever (NYSE: UL). Colgate has a...
